HealthEquity (NASDAQ:HQY) Lowered to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of HealthEquity (NASDAQ:HQY) from a buy rating to a hold rating in a research report sent to investors on Sunday morning.

A number of other research analysts have also weighed in on the stock. BTIG Research reissued a “buy” rating and set a $130.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Barclays began coverage on HealthEquity in a research note on Monday, December 8th. They issued an “overweight” rating and a $118.00 price objective on the stock. KeyCorp boosted their price objective on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday. JMP Securities set a $122.00 target price on HealthEquity in a report on Thursday, December 4th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $119.60.

HealthEquity Stock Performance

Shares of HQY opened at $94.15 on Friday. The firm has a market cap of $8.04 billion, a price-to-earnings ratio of 43.19, a price-to-earnings-growth ratio of 1.36 and a beta of 0.20. The company’s fifty day moving average is $97.04 and its 200-day moving average is $95.14. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity has a 12 month low of $74.07 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same period last year, the business earned $0.78 EPS. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts expect that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Activity

In related news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,459 shares of company stock worth $1,483,062 over the last 90 days. Corporate insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Norges Bank acquired a new position in shares of HealthEquity in the 2nd quarter valued at $75,072,000. Westfield Capital Management Co. LP boosted its position in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares in the last quarter. AQR Capital Management LLC increased its stake in HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares during the period. Woodline Partners LP acquired a new position in HealthEquity in the third quarter worth about $26,193,000. Finally, Vanguard Group Inc. raised its position in HealthEquity by 2.9% in the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after purchasing an additional 243,549 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.